Scarica l'app Stockscreener
2.00
2.08%
0.08
Precedente Chiudi:
$1.92
Aprire:
$1.96
Volume 24 ore:
1,228
Relative Volume:
0.02
Capitalizzazione di mercato:
$20.50M
Reddito:
$10.16M
Utile/perdita netta:
$-47.57M
Rapporto P/E:
-0.2427
EPS:
-8.24
Flusso di cassa netto:
$-42.73M
1 W Prestazione:
-3.45%
1M Prestazione:
+30.67%
6M Prestazione:
-51.36%
1 anno Prestazione:
-82.41%
Intervallo 1D:
$1.96
$1.96
Intervallo di 1 settimana:
$1.84
$2.19
Portata 52W:
$1.02
$11.46
Curis Inc Stock (CRIS) Company Profile
Nome
Curis Inc
Settore
Industria
Telefono
617-503-6500
Indirizzo
128 SPRING STREET, LEXINGTON, MA
Confronta CRIS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CRIS
Curis Inc
|
1.96 | 20.92M | 10.16M | -47.57M | -42.73M | -8.24 |
|
ONC
Beigene Ltd Adr
|
238.32 | 24.41B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
429.69 | 111.55B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.2548 | 42.47M | 0 | 0 | 0 | 0.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.43 | 63.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
VRNA
Verona Pharma Plc Adr
|
72.00 | 5.92B | 0 | -153.72M | -103.81M | -2.00 |
Curis Inc Stock (CRIS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-19 | Ripresa | H.C. Wainwright | Buy |
| 2023-11-17 | Iniziato | Truist | Buy |
| 2022-04-04 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2021-10-13 | Iniziato | Raymond James | Outperform |
| 2021-03-25 | Iniziato | B. Riley Securities | Buy |
| 2020-07-29 | Iniziato | Laidlaw | Buy |
| 2020-07-17 | Iniziato | Cantor Fitzgerald | Overweight |
| 2017-10-24 | Iniziato | Guggenheim | Buy |
| 2016-03-02 | Iniziato | Sun Trust Rbsn Humphrey | Buy |
| 2015-11-09 | Reiterato | ROTH Capital | Buy |
| 2015-08-11 | Iniziato | FBR Capital | Outperform |
| 2015-01-22 | Reiterato | Oppenheimer | Outperform |
| 2015-01-21 | Reiterato | ROTH Capital | Buy |
| 2014-05-09 | Reiterato | Oppenheimer | Outperform |
| 2013-10-02 | Iniziato | Robert W. Baird | Outperform |
| 2013-09-30 | Iniziato | Chardan Capital Markets | Buy |
| 2012-11-14 | Iniziato | Stifel Nicolaus | Hold |
| 2012-01-31 | Reiterato | Brean Murray | Buy |
| 2012-01-31 | Reiterato | Summer Street Research | Buy |
| 2011-12-09 | Iniziato | Oppenheimer | Outperform |
| 2011-10-06 | Iniziato | Summer Street Research | Buy |
| 2011-09-22 | Iniziato | MLV Capital | Buy |
| 2011-03-21 | Reiterato | Brean Murray | Buy |
| 2010-02-26 | Reiterato | Roth Capital | Buy |
| 2010-01-07 | Iniziato | Roth Capital | Buy |
Mostra tutto
Curis Inc Borsa (CRIS) Ultime notizie
Curis Approves Key Amendments at Annual Meeting - TipRanks
What is HC Wainwright’s Estimate for Curis Q2 Earnings? - Defense World
Curis (NASDAQ:CRIS) Receives Buy Rating from HC Wainwright - Defense World
Curis (CRIS) Sees Positive Rating Action from HC Wainwright & Co - GuruFocus
Curis assumed with a Buy at H.C. Wainwright - TipRanks
H.C. Wainwright sets $17 target for Curis stock with Buy rating - Investing.com Nigeria
Curis (CRIS) Gains Buy Rating with Promising Cancer Therapy Deve - GuruFocus
Curis (CRIS) Gains Buy Rating with Promising Cancer Therapy Developments | CRIS Stock News - GuruFocus
Curis Provides Third Quarter 2023 Business Update - Seeking Alpha
Curis (NASDAQ:CRIS) Now Covered by Analysts at StockNews.com - Defense World
FY2025 EPS Estimates for Curis Reduced by Cantor Fitzgerald - Defense World
Curis highlights progress in lymphoma and AML trials with expanded patient enrollment - MSN
Curis, Inc. (NASDAQ:CRIS) Q1 2025 Earnings Call Transcript - Insider Monkey
Analysts Offer Insights on Healthcare Companies: Curis (CRIS), Ardent Health Partners, Inc. (ARDT) and Agilon Health (AGL) - The Globe and Mail
Curis (NASDAQ:CRIS) Coverage Initiated at StockNews.com - Defense World
Curis (CRIS) Reports Q1 Loss, Tops Revenue Estimates - MSN
Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | CRIS Stock News - GuruFocus
Curis Inc (CRIS) Q1 2025 Earnings Call Highlights: Financial Improvements and Strategic Developments - Yahoo Finance
Curis Inc (CRIS) Q1 2025 Earnings Call Highlights: Financial Imp - GuruFocus
Curis Inc (CRIS) Q1 2025 Earnings Call Highlights: Financial Improvements and Strategic Developments By GuruFocus - Investing.com Canada
Curis Inc. Reports Q1 2025 Progress and Financials - TipRanks
Curis Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Curis Inc. Earnings Call: Clinical Advances Amid Cash Concerns - TipRanks
Curis: Q1 Earnings Snapshot - MySA
Curis Q1 2025 Earnings Call Transcript - MarketBeat
Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - GuruFocus
Curis, Inc. (CRIS) Advances Emavusertib Studies with Positive Da - GuruFocus
Curis (CRIS) Strengthens Leadership with New Chief Medical Officer | CRIS Stock News - GuruFocus
Curis appoints Ahmed Hamdy as Chief Medical Officer - TipRanks
Curis reports Q1 EPS ($1.25), consensus ($1.26) - TipRanks
Earnings call transcript: Curis Inc. Q1 2025 sees stock surge despite losses - Investing.com India
Curis Provides First Quarter 2025 Business Update - StreetInsider
Curis (CRIS) Expands Leadership and Advances Clinical Studies | - GuruFocus
Curis Provides First Quarter 2025 Business Update | CRIS Stock N - GuruFocus
Curis Inc (CRIS) Q1 2025 Earnings: EPS of -$1.25 Misses Estimates, Revenue of $2.4M Falls Short - GuruFocus
Curis (CRIS) Expands Leadership and Advances Clinical Studies | CRIS Stock News - GuruFocus
Curis Provides First Quarter 2025 Business Update | CRIS Stock News - GuruFocus
CURIS INC SEC 10-Q Report - TradingView
Curis Inc Q1 Loss Decreases, Beats Estimates - Nasdaq
Curis Inc (CRIS) Q1 2025 Earnings Report Preview: What To Expect - GuruFocus
Curis Provides Third Quarter 2024 Business Update - Seeking Alpha
Geode Capital Management LLC Raises Position in Curis, Inc. (NASDAQ:CRIS) - Defense World
Curis FY2025 EPS Estimate Increased by Cantor Fitzgerald - Defense World
Curis Inc Azioni (CRIS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
4.37%
2.24%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):